# Vortioxetine Adjunctive Treatment in Bipolar Depression

> **NCT05481957** · PHASE4 · COMPLETED · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 131 (actual)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** Vortioxetine
- **DRUG:** valprote

## Key facts

- **NCT ID:** NCT05481957
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2023-06-28
- **Final completion:** 2023-08-15
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2023-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05481957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05481957, "Vortioxetine Adjunctive Treatment in Bipolar Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05481957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*